Safety and efficacy of New-Fill® (Polylactic acid) in the treatment of HIV-associated lipoatrophy of the face (HALF)

被引：0
|
作者：
Engelhard, P [1 ]
Knies, M [1 ]
机构：
[1] Apex S Beach, Miami Beach, FL USA
来源：
XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE | 2002年
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Various techniques have been employed in an attempt to correct the cosmetic facial defects caused by HIV-Associated Lipoatrophy of the Face (HALF) (1). This study presents data regarding the short-term (6 month) efficacy and safety of New-Fill(R) (Polylactic Acid) in the treatment of HALF. Overall, treatment with New-Fill(R) results in significant improvement in subject self-reported lipoatrophy rating and good subject satisfaction with treatment outcome at 6 months.
引用
收藏
页码：365 / 367
页数：3
相关论文
共 50 条
  • [21] Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV plus patients under tritherapy
    Piquet, M.
    Brignol, L.
    Chatelain, B.
    Rey, D.
    Ricbourg, B.
    Meyer, C.
    REVUE DE STOMATOLOGIE DE CHIRURGIE MAXILLO-FACIALE ET DE CHIRURGIE ORALE, 2007, 108 (06) : 496 - 504
  • [22] Objective evidence for the use of polylactic acid implants in HIV-associated facial lipoatrophy using three-dimensional surface laser scanning and psychological assessment
    Ong, J.
    Clarke, A.
    White, P.
    Johnson, M. A.
    Withey, S.
    Butler, P. E. M.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2009, 62 (12): : 1627 - 1635
  • [23] Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and Morphology with MRI
    Becker, Minerva
    Balague, Nicolas
    Montet, Xavier
    Calmy, Alexandra
    Salomon, Denis
    Toutous-Trellu, Laurence
    DERMATOLOGY, 2015, 230 (04) : 367 - 374
  • [24] Correction of HIV-Associated Facial Lipoatrophy: Autologous Fat Grafting versus Hyaluronic Acid Fillers
    Mashiko, Takanobu
    Tsukada, Kunihisa
    Shirado, Takako
    Oka, Shinichi
    Yoshimura, Kotaro
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 153 (01) : 222e - 225e
  • [25] Late-Onset Infections and Granuloma Formation after Facial Polylactic Acid (New-Fill) Injections in Women Who Are Heavy Smokers
    Azizzadeh, Babak
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 124 (01) : 316 - 317
  • [26] Late-Onset Infections and Granuloma Formation after Facial Polylactic Acid (New-Fill) Injections in Women Who Are Heavy Smokers
    Goldan, O.
    Garbov-Nardini, G.
    Regev, E.
    Orenstein, A.
    Winkler, E.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 121 (05) : 336E - 338E
  • [27] Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: a review of the clinical studies
    Barton, S. E.
    Engelhard, P.
    Conant, M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (07) : 429 - 435
  • [28] Efficacy and Toxicity of Chemoradiation in the Treatment of HIV-Associated Anal Cancer
    Hauerstock, David
    Ennis, Ronald D.
    Grossbard, Michael
    Evans, Andrew
    CLINICAL COLORECTAL CANCER, 2010, 9 (04) : 238 - 242
  • [29] Infectious complications of Bio-Alcamid™ soft tissue endoprosthesis treatment of HIV-associated facial lipoatrophy
    Nadarajah, J.
    Collins, M.
    Loutfy, M.
    Walmsley, S.
    ANTIVIRAL THERAPY, 2010, 15 : A22 - A23
  • [30] Four-Year Follow-Up of Polyalkylimide Gel Use for the Treatment of HIV-Associated Lipoatrophy
    Loutfy, Mona R.
    Brunetta, Jason
    Kovacs, Colin
    Diong, Christina
    Gamble, Molly
    Antoniou, Tony
    Smith, Graham
    Halpenny, Roberta
    Rosenes, Ron
    Raboud, Janet M.
    HIV CLINICAL TRIALS, 2011, 12 (06): : 323 - 332
12345